Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.700
+0.010 (0.59%)
At close: Sep 17, 2026, 4:00 PM EDT
1.720
+0.020 (1.18%)
After-hours: Sep 17, 2026, 7:30 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $296.26 million as of September 17, 2026. Its market cap has increased by 5,293.04% in one year.
Market Cap
296.26M
Enterprise Value
171.09M
1-Year Change
5,293.04%
Ranking
Category
Stock Price
$1.70
ChartMarket Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $296.26M, an increase of 294.65%. That is a compound annual growth rate of 29.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 296.26M | -15.39% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 373.11M |
| Orchestra BioMed Holdings | 363.03M |
| Evommune | 362.56M |
| X4 Pharmaceuticals | 358.91M |
| Century Therapeutics | 358.53M |
| Enanta Pharmaceuticals | 357.95M |
| DiaMedica Therapeutics | 352.13M |
| Lexeo Therapeutics | 338.84M |